1130067-18-3

VU0155056 has been used as a phospholipase D-1 (PLD1) inhibitor:

• to study its role in regulated exocytosis
• to test bacterial and human PLD enzymes for specificity of inhibition
• in neuro-2a (N2a) cell culture and survival assay

ChEBI: N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-2-naphthalenecarboxamide is a naphthalenecarboxamide.

VU0155056 or N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl ethyl)-2-naphthamide is a cell permeable phospholipase D (PLD) inhibitor. It inhibits both PLD1 and PLD2.